Evidence map›Paper›PMID 37272216›Full record

ArticleEuropean journal of neurology2025

Cognitive deficits in patients with peripheral vestibular dysfunction.

Mark Obermann, Alexander Gebauer, Diana Arweiler-Harbeck, Stephan Lang, Bernd Seilheimer, Christoph Kleinschnitz, Hans-Christoph Diener, Dagny Holle, Steffen Naegel

Abstract read
In one paragraph

Article in European journal of neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Neurological update: neuro-otology 2023.Journal of neurology · 2023
    Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Mark ObermannDepartment of Neurology, Dizziness and Vertigo Center Essen, University Hospital Essen, Essen, Germany.ORCID 0000-0002-5533-2657
Alexander GebauerDepartment of Neurology, Dizziness and Vertigo Center Essen, University Hospital Essen, Essen, Germany.
Diana Arweiler-HarbeckDepartment of Otorhinolaryngology, University Hospital Essen, Essen, Germany.
Stephan LangDepartment of Otorhinolaryngology, University Hospital Essen, Essen, Germany.
Bernd SeilheimerMedical Affairs & Research, Heel, Baden-Baden, Germany.
Christoph KleinschnitzDepartment of Neurology, Dizziness and Vertigo Center Essen, University Hospital Essen, Essen, Germany.
Hans-Christoph DienerDepartment of Neuroepidemiology, Institute for Medical Informatics, Biometry, and Epidemiology, University of Duisburg-Essen, Essen-Werden, Germany.ORCID 0000-0002-6556-8612
Dagny HolleDepartment of Neurology, Dizziness and Vertigo Center Essen, University Hospital Essen, Essen, Germany.
Steffen NaegelDepartment of Neurology, Dizziness and Vertigo Center Essen, University Hospital Essen, Essen, Germany.

Funding

Heel GmbH
6 · The paper itself

Abstract

background and purposePrevious studies demonstrated cognitive deficits in patients with peripheral vestibulopathy (PVP) with dysfunction of spatial navigation and orientation, but also documented cognitive decline in nonspatial abilities. This study evaluates cognitive deficits in patients with unilateral vestibulopathy (UVP) as well as bilateral vestibulopathy (BVP) in multiple cognitive domains using common screening tests to reliably detect these deficits in clinical practice.

methodsThis prospective study compared patients with UVP and BVP to age- and sex-matched healthy controls (HC). Tests included the Alzheimer's Disease Assessment Scale (ADAS), Mini-Mental Status Examination (MMSE), Trail Making Test Part A and B, Clock Drawing Task, Executive Interview-25 (EXIT25), Dementia Detection (DemTect), and the Judgment of Line Orientation (JLO). The Montgomery-Åsberg Depression Rating Scale was used to control for depression. Videonystagmography objectively reconfirmed PVP. The Vertigo Symptoms Scale and the Dizziness Handicap Inventory were used to assess for symptom severity and restrictions of activities of daily living.

resultsEighty-one patients (65 UVP, 16 BVP) were compared to 55 HC. Patients showed impairment in ADAS, MMSE, DemTect, EXIT25, and JLO. No differences between UVP and BVP were detected. The relative risk (RR) estimates of developing cognitive deficits following PVP were increased. The RR for the ADAS was higher in BVP (RR = 4.91, 95% confidence interval [CI] = 1.87-12.9, p = 0.001) than in UVP (RR = 3.75, 95% CI = 1.65-8.51, p = 0.002), but was similar for the MMSE and DemTect between groups.

conclusionsPatients with PVP showed deficits in multiple cognitive domains including nonspatial cognitive abilities. Vestibulopathy could be a risk factor for the development of cognitive impairment.

Indexed as

Cognitive DysfunctionAgedAged, 80 and overBilateral VestibulopathyFemaleHumansMaleMiddle AgedNeuropsychological TestsProspective StudiesVestibular Diseasescognitive deficitdementianonspatial abilitiesperipheral vestibulopathyscreening tests

Identifiers

PMID37272216
PMCPMC11618113

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.